286 related articles for article (PubMed ID: 32748889)
1. Orally Administered Exosomes Suppress Mouse Delayed-Type Hypersensitivity by Delivering miRNA-150 to Antigen-Primed Macrophage APC Targeted by Exosome-Surface Anti-Peptide Antibody Light Chains.
Nazimek K; Bryniarski K; Ptak W; Groot Kormelink T; Askenase PW
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32748889
[TBL] [Abstract][Full Text] [Related]
2. Antibody Light Chains Dictate the Specificity of Contact Hypersensitivity Effector Cell Suppression Mediated by Exosomes.
Nazimek K; Askenase PW; Bryniarski K
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205452
[TBL] [Abstract][Full Text] [Related]
3. Syngeneic red blood cell-induced extracellular vesicles suppress delayed-type hypersensitivity to self-antigens in mice.
Nazimek K; Bustos-Morán E; Blas-Rus N; Nowak B; Ptak W; Askenase PW; Sánchez-Madrid F; Bryniarski K
Clin Exp Allergy; 2019 Nov; 49(11):1487-1499. PubMed ID: 31365154
[TBL] [Abstract][Full Text] [Related]
4. Macrophages play an essential role in antigen-specific immune suppression mediated by T CD8⁺ cell-derived exosomes.
Nazimek K; Ptak W; Nowak B; Ptak M; Askenase PW; Bryniarski K
Immunology; 2015 Sep; 146(1):23-32. PubMed ID: 25808106
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity.
Bryniarski K; Ptak W; Jayakumar A; Püllmann K; Caplan MJ; Chairoungdua A; Lu J; Adams BD; Sikora E; Nazimek K; Marquez S; Kleinstein SH; Sangwung P; Iwakiri Y; Delgato E; Redegeld F; Blokhuis BR; Wojcikowski J; Daniel AW; Groot Kormelink T; Askenase PW
J Allergy Clin Immunol; 2013 Jul; 132(1):170-81. PubMed ID: 23727037
[TBL] [Abstract][Full Text] [Related]
6. Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells.
Bryniarski K; Ptak W; Martin E; Nazimek K; Szczepanik M; Sanak M; Askenase PW
PLoS One; 2015; 10(4):e0122991. PubMed ID: 25923429
[TBL] [Abstract][Full Text] [Related]
7. Exosomes carry IL-10 and antigen/MHC II complexes to induce antigen-specific oral tolerance.
Zeng HT; Liu JQ; Zhao M; Yu D; Yang G; Mo LH; Liu ZQ; Wang S; Liu ZG; Yang PC
Cytokine; 2020 Sep; 133():155176. PubMed ID: 32563958
[TBL] [Abstract][Full Text] [Related]
8. Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model.
Yang C; Kim SH; Bianco NR; Robbins PD
PLoS One; 2011; 6(8):e22517. PubMed ID: 21829629
[TBL] [Abstract][Full Text] [Related]
9. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
Matsushima GK; Stohlman SA
J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
[TBL] [Abstract][Full Text] [Related]
10. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
Ptak W; Herzog WR; Askenase PW
J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
[TBL] [Abstract][Full Text] [Related]
11. Delayed-Type Hypersensitivity Underlying Casein Allergy Is Suppressed by Extracellular Vesicles Carrying miRNA-150.
Wąsik M; Nazimek K; Nowak B; Askenase PW; Bryniarski K
Nutrients; 2019 Apr; 11(4):. PubMed ID: 31018604
[TBL] [Abstract][Full Text] [Related]
12. Plasma-derived MHC class II+ exosomes from tumor-bearing mice suppress tumor antigen-specific immune responses.
Yang C; Ruffner MA; Kim SH; Robbins PD
Eur J Immunol; 2012 Jul; 42(7):1778-84. PubMed ID: 22585706
[TBL] [Abstract][Full Text] [Related]
13. From Mysterious Supernatant Entity to miRNA-150 in Antigen-Specific Exosomes: a History of Hapten-Specific T Suppressor Factor.
Ptak W; Nazimek K; Askenase PW; Bryniarski K
Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):345-56. PubMed ID: 25690461
[TBL] [Abstract][Full Text] [Related]
14. Ag and IL-2 immune complexes efficiently expand Ag-specific Treg cells that migrate in response to chemokines and reduce localized immune responses.
Hamano R; Baba T; Sasaki S; Tomaru U; Ishizu A; Kawano M; Yamagishi M; Mukaida N
Eur J Immunol; 2014 Apr; 44(4):1005-15. PubMed ID: 24338997
[TBL] [Abstract][Full Text] [Related]
15. Enhanced generation of reactive oxygen intermediates by suppressor T cell-derived exosome-treated macrophages.
Nazimek K; Nowak B; Marcinkiewicz J; Ptak M; Ptak W; Bryniarski K
Folia Med Cracov; 2014; 54(1):37-52. PubMed ID: 25556365
[TBL] [Abstract][Full Text] [Related]
16. The role of antigen recognition and suppressor cells in mice with oral tolerance to ovalbumin.
Mowat AM
Immunology; 1985 Oct; 56(2):253-60. PubMed ID: 2932384
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity and oral tolerance in the absence of a secretory immune system.
Karlsson MR; Johansen FE; Kahu H; Macpherson A; Brandtzaeg P
Allergy; 2010 May; 65(5):561-70. PubMed ID: 19886928
[TBL] [Abstract][Full Text] [Related]
18. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
[TBL] [Abstract][Full Text] [Related]
19. Oral tolerization leads to active suppression and bystander tolerance in adult rats while anergy dominates in young rats.
Lundin BS; Dahlgren UI; Hanson LA; Telemo E
Scand J Immunol; 1996 Jan; 43(1):56-63. PubMed ID: 8560197
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
